Validating disease targets using open access chemical probes
The inaugural Industry and Academic Collaboration Award will be awarded in 2018 to Stefan Knapp from the Institute of Pharmaceutical Chemistry, the Buchmann Institute for Molecular Life Sciences at Frankfurt University as well as at the Structural Genomics Consortium at Oxford University.
His research team made a major contribution to the understanding of structural mechanisms regulating signalling molecules such as protein kinases, phosphatases, acetylation dependent reader domains of the bromodomain family and the exploitation of this knowledge for the development of highly specific inhibitors. In the framework of a large collaborative network involving many academic research groups and industry, he pioneered the development of protein interaction inhibitors targeting bromodomains that function as lysine acetylation dependent reader domains of the epigenetic code as well as highly specific allosteric inhibitors modulating kinase function.
The lecture, entitled 'Validating disease targets using open access chemical probes' will take place at the Brighton and Sussex Medical School Teaching Building, University of Sussex, UK.
Register to attend
The lecture is free to attend and open to all.
16:00-17:00 Award presentation and lecture
Validating disease targets using open access chemical probe
17:00-18:00 Drinks reception